Fragments X, the 10th RSC-BMCS Fragment-based Drug Discovery Meeting, runs September 14 to 16, 2026 at Churchill College, Cambridge.

Fragment-to-lead progression rewards a binding mode you can trust and chemistry that reaches potency in as few cycles as possible. Crystallographic fragment screening delivers both: every hit arrives as a 3D structure, and every fragment in our library is a synthon of make-on-demand chemical space.

Flash talk FT04, Monday, September 14, 5:30 PM
Poster P31, Fast structure-guided fragment-to-hit evolution enabled by crystallographic fragment screening

Dr. Jan Wollenhaupt, who leads crystallographic fragment screening at Proteros, and Dr. Sadaf Kasraie, VP, Strategic Business Development, will be at the meeting throughout all three days.

Reach out to arrange a meeting.